BackRhythm Pharmaceuticals Overview

Rhythm Pharmaceuticals Current Cash

Track Rhythm Pharmaceuticals's current cash ($66M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$65.61M
51.61% YoYΔ $-69.97M vs prior year quarter

Peer trimmed avg / median

Loading

Rhythm Pharmaceuticals Current Cash History

Loading

Rhythm Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Rhythm Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rhythm Pharmaceuticals (RYTM) FAQ

As of the most recent data (June 2026), RYTM shows a current cash of $66M. That compares with $140M in the prior-year period — down 51.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RYTM's current cash is now $66M (was $140M) — a 51.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rhythm Pharmaceuticals is outperforming or lagging.

Tracking RYTM's current cash over time shows whether Rhythm Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $66M That compares with $140M in the prior-year period — down 51.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Rhythm Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $66M) with ownership activity and broader fundamentals.

Rhythm Pharmaceuticals's current cash is $66M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.